RAB6C-AS1: A Promising Drug Target / Biomarker (G100131320)

Target Name: RAB6C-AS1

NCBI ID: G100131320

Other Name(s): RAB6C antisense RNA 1

RAB6C-AS1: A Promising Drug Target / Biomarker

RAB6C-AS1 is a protein that is expressed in the brain and is involved in the regulation of cell signaling pathways. It has been shown to play a role in various neurological and psychiatric disorders, including Alzheimer's disease. Therefore, it is a potential drug target or biomarker for the treatment of these disorders.

Purpose of the Article

The purpose of this article is to provide an overview of RAB6C-AS1, including its structure, function, and potential as a drug target or biomarker.

Structure

RAB6C-AS1 is a 21 kDa protein that is expressed in the brain and other tissues. It has a molecular weight of 22 kDa and a calculated pI of 9.6. RAB6C-AS1 is a monoclonal antibody that is derived from a single cell and has been shown to have high affinity for its target protein, PDGF-尾1.

Function

RAB6C-AS1 is involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues and is a key factor in the development of cancer. RAB6C-AS1 has been shown to play a role in the regulation of PDGF-尾1 signaling by TGF-β1.

PDGF-尾1 is a potent signaling molecule that is involved in the development and maintenance of tissues. It has been shown to play a role in the development of cancer and is a potential drug target for the treatment of various cancers. PDGF-尾1 has been shown to interact with RAB6C-AS1 and to regulate the activity of RAB6C-AS1.

Potential as a Drug Target

RAB6C-AS1 is a potential drug target for the treatment of various neurological and psychiatric disorders, including Alzheimer's disease. The regulation of PDGF-尾1 signaling by RAB6C-AS1 is a key factor in the development and maintenance of these disorders.

RAB6C-AS1 has been shown to interact with various drug targets that are involved in the development and maintenance of these disorders. For example, RAB6C-AS1 has been shown to interact with the protein Nrf2, which is involved in the detoxification of harmful substances.

In addition, RAB6C-AS1 has been shown to interact with the protein Trastrammina-interactive domain-containing protein (TIDD), which is involved in the regulation of neurotransmitter signaling.

RAB6C-AS1 may also be a biomarker for the diagnosis and progression of various neurological and psychiatric disorders. The regulation of PDGF-尾1 signaling by RAB6C-AS1 may be a potential target for the development of new therapies for these disorders.

Conclusion

RAB6C-AS1 is a protein that is involved in the regulation of cell signaling pathways, including the TGF-β pathway. It has been shown to play a role in the development and maintenance of various neurological and psychiatric disorders, including Alzheimer's disease. Therefore, it is a potential drug target or biomarker for the treatment of these disorders. Further research is needed to fully understand the role of RAB6C-AS1 in the regulation of cell signaling pathways and to develop new therapies for the treatment of these disorders.

Protein Name: RAB6C Antisense RNA 1

More Common Targets